Pharmafile Logo
Pharmafocus logo
Advanced Search

Business Services

Pharmaceutical Business Services – News, analysis and company profiles

Showing 15 posts of 2459 posts found.

Veeva MedTech Clinical Trials Report Signals Significant Opportunity to Improve Data Delivery and Quality

April 19, 2023 Business Services

BARCELONA, Spain — 19 Apr. 2023 — Veeva Systems (NYSE: VEEV) today released its first-ever report examining global trends in …
News
Press release

Growth in global demand for pure medical cannabis sees Lesotho-based cultivator and manufacturer expand its production

April 19, 2023 Business Services

19 April 2023, Maseru – Licensed cultivator and manufacturer of medical-grade cannabis extracts and products,
News
Press release

Revolo Biotherapeutics Announces Positive Topline Data from Phase 2a Trial of ‘1104 in Adults with Active Eosinophilic Esophagitis

April 19, 2023 Business Services

NEW ORLEANS and CAMBRIDGE, UK, April 19 2023 – Revolo Biotherapeutics (“Revolo” or the “Company”), a company developing therapies that …
News
Press release
lars_nieba_002

Engimmune Therapeutics appoints Dr. Lars Nieba as Chief Executive Officer

April 19, 2023 Business Services

Basel, Switzerland, April 19, 2023. Engimmune Therapeutics AG (“Engimmune”), a Swiss biotech company developing novel T-cell receptor (TCR)-based therapeutics, today …
Appointment

Oxford BioTherapeutics announces Phase 1b trial in collaboration with GORTEC to investigate OBT076 in Adenoid Cystic Carcinoma (ACC) of the head and neck

April 19, 2023 Business Services

Oxford, UK and San Jose, Calif., 19 April 2023 – Oxford BioTherapeutics Ltd.
News
Press release

OWEN MUMFORD WINS DISTINCTION IN RED DOT AWARD (PRODUCT DESIGN 2023) FOR AIDAPTUS® AUTO-INJECTOR

April 18, 2023 Business Services

OXFORD, England, 18 April 2023 – Owen Mumford is proud to have been awarded a distinction in the prestigious Red …
News
Press release

Pneumagen further strengthens IP protection for lead product Neumifil with granting of US composition of matter patent

April 18, 2023 Business Services

St Andrews, UK – 18 April 2023 – Pneumagen, a clinical stage biotech company developing Neumifil, a broad-spectrum antiviral, intranasal …
News
Press release

NeoPhore signs research collaboration with The Institute of Cancer Research, London

April 18, 2023 Business Services

London, UK, 18 April 2023, – NeoPhore Limited, a small molecule neoantigen immuno-oncology company, today announces that it has signed a …
News
Press release

New Data Showing that Transgene and NEC’s Individualized Cancer Vaccine TG4050 Induces Strong and Specific Immune Responses against Tumors Presented at AACR 2023

April 18, 2023 Business Services

Strasbourg, France & Tokyo, Japan, April 18, 2023, 9:00 a.m. CET/4:00 p.m. JST – Transgene (Euronext Paris: TNG), a biotech company …
News
Press release

Nouscom Presents New Positive Translational Phase 1b Data of NOUS-PEV, a Personalized Neoantigen Cancer Immunotherapy, in a Late-Breaking Abstract at AACR 2023

April 18, 2023 Business Services

BASEL, Switzerland – 18th April 2023 – Nouscom, a clinical stage immuno-oncology company developing off-the-shelf and personalized viral vector immunotherapies, …
News
Press release

MED3000, Eroxon® UK Launch

April 18, 2023 Business Services

Futura Medical plc (AIM: FUM) (“Futura” or the “Company”), a pharmaceutical company developing a portfolio of innovative products based on …
News
Press release

Scancell to present ModiFY Phase 1/2 cancer vaccine clinical trial protocol and early efficacy data at the American Association for Cancer Research Annual Meeting

April 18, 2023 Business Services

Scancell Holdings plc (AIM: SCLP), the developer of novel immunotherapies for the treatment of cancer and infectious disease, announces it …
News
Press release

HUTCHMED Announces NDA Acceptance in China for Fruquintinib in Second-Line Gastric Cancer

April 18, 2023 Business Services

Hong Kong, Shanghai & Florham Park, NJ — Tuesday, April 18, 2023: HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:​HCM; HKEX:​13) today announces …
News
Press release

We need more “trial” and less error – a concerted effort is required to include more people aged over 60 in clinical trials, argues longevity experts

April 18, 2023 Business Services

The Trial and error report, published today, urges regulators, pharmaceutical companies and researchers to prioritise age diversity at all stages …
News
Press release

Cantargia presents new clinical data at AACR 2023 strongly supporting nadunolimab development in pancreatic cancer

April 17, 2023 Business Services

Cantargia (Cantargia AB; Nasdaq Stockholm: CANTA) today presented updated interim clinical efficacy data including subgroup analyses of first-line pancreatic cancer …
News
Press release
The Gateway to Local Adoption Series

Latest content

Sandoz opens biosimilar development centre in Slovenia

June 19, 2026

Codis announces three senior business development appointments

June 18, 2026

US laboratory approval supports launch of lung cancer blood test

June 17, 2026

Study to examine ways of improving diabetes care for younger adults

June 16, 2026

Phase 2 endometriosis trial reaches recruitment milestone

June 15, 2026